Journal of Clinical Endocrinology & Metabolism, Vol 76, 873-878, Copyright © 1993 by Endocrine Society

ARTICLES

The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism

S Ulick, JD Blumenfeld, SA Atlas, JZ Wang and ED Vaughan Jr
Veterans Affairs Hospital, Bronx, New York 10468.

18-Hydroxycortisol and 18-oxocortisol have been isolated from the urine of patients with aldosterone producing adrenocortical adenomas, but not from those with idiopathic hyperaldosteronism associated with bilateral adrenal hyperplasia. These C-18 oxygenated cortisols are biosynthesized by the substitution of cortisol for the normal substrate, corticosterone, in the terminal oxidase system required for the biosynthesis of 18-hydroxycorticosterone and aldosterone. To make use of this biochemical difference between the two groups in the preoperative diagnosis of primary aldosteronism, we have developed and utilized a specific primary standard analytical method, stable isotope dilution mass fragmentography, for quantifying 18-hydroxycortisol and the tetrahydro metabolite of 18-oxocortisol in 24-h urine samples. The normal range by this technique of 4.6 +/- 1.8 micrograms/day tetrahydro 18-oxocortisol and 43 +/- 23 micrograms/day 18-hydroxycortisol in urine was lower and narrower than previous estimates using other methods. Excretion of the 18-oxocortisol metabolite ranged from 2-12 micrograms/day in bilateral hyperplasia and 17-1203 micrograms/day in typical adenomas. 18-Hydroxycortisol excretion similarly separated bilateral hyperplasia (23-59 micrograms/day) from typical adenomas (60- 2750 micrograms/day). The cortisol C-18 oxidation pathway describes a unique steroidogenic mechanism in the aldosteronoma not present in idiopathic aldosteronism due to bilateral adrenal hyperplasia and as such provides a basis for the biochemical classification of primary aldosteronism and the differentiation of these two groups. This unique biochemistry was also observed in unilateral hyperplasia but not in the renin-dependent aldosteronoma.

This article has been cited by other articles:

				C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Rudiger, C. Nickel, F. Beuschlein, and M. Reincke Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur. J. Endocrinol., June 1, 2006; 154(6): 865 - 873. [Abstract] [Full Text] [PDF]

				L. Mosso, C. E. Gomez-Sanchez, M. F. Foecking, and C. Fardella Serum 18-Hydroxycortisol in Primary Aldosteronism, Hypertension, and Normotensives Hypertension, September 1, 2001; 38(3): 688 - 691. [Abstract] [Full Text] [PDF]

				C. E. Fardella, L. Mosso, C. Gómez-Sánchez, P. Cortés, J. Soto, L. Gómez, M. Pinto, A. Huete, E. Oestreicher, A. Foradori, et al. Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1863 - 1867. [Abstract] [Full Text]

				R. Harper, C.G. Ferrett, J.A. McKnight, E.M. McIlrath, C.F. Russell, B. Sheridan, and A.B. Atkinson Accuracy of CT scanning and adrenal vein sampling in the pre-operative localization of aldosterone-secreting adrenal adenomas QJM, November 1, 1999; 92(11): 643 - 650. [Abstract] [Full Text] [PDF]

				J. H. Pratt, J. F. Rebhun, L. Zhou, W. T. Ambrosius, S. A. Newman, C. E. Gomez-Sanchez, and D. F. Mayes Levels of Mineralocorticoids in Whites and Blacks Hypertension, August 1, 1999; 34(2): 315 - 319. [Abstract] [Full Text] [PDF]

				A. Ganguly Primary Aldosteronism N. Engl. J. Med., December 17, 1998; 339(25): 1828 - 1834. [Full Text] [PDF]

				P. Mulatero, K. M. Curnow, B. Aupetit-Faisant, M. Foekling, C. Gomez-Sanchez, F. Veglio, X. Jeunemaitre, P. Corvol, and L. Pascoe Recombinant CYP11B Genes Encode Enzymes that Can Catalyze Conversion of 11-Deoxycortisol to Cortisol, 18-Hydroxycortisol, and 18-Oxocortisol J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3996 - 4001. [Abstract] [Full Text]

				P. Mulatero, F. Veglio, C. Pilon, F. Rabbia, C. Zocchi, P. Limone, M. Boscaro, N. Sonino, and F. Fallo Diagnosis of Glucocorticoid-Remediable Aldosteronism in Primary Aldosteronism: Aldosterone Response to Dexamethasone and Long Polymerase Chain Reaction for Chimeric Gene J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2573 - 2575. [Abstract] [Full Text]